As noted in my previous question, most of the mitochondrial proteins are encoded by nuclear DNA and not mtDNA. Certain types of mitochondrial disease arise not from primary defects with the mitochondria, but rather from mutations in the genome that are associated with mitochondrial function. This causes the same mitochondrial-deficient phenotype as mutations in mtDNA, but because mutations such as in PGC1 are not localized to the mitochondria, patients would not benefit from a mitochondrial donation. Will patients with mitochondrial diseases who would not benefit from the procedure be screened out? Is this technically feasible? Would the pathophysiology of each candidate's disease need to be worked out in order to only provide treatment to those who stand to benefit?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.